SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (90)2/26/1999 4:17:00 PM
From: RCMac  Respond to of 423
 
>>curious on the thread's take on CORR.<<
Tuck, in addition to the CORR thread on SI, there has been some discussion on the "NIFTY NINE . . ." thread, including my post of a couple of weeks ago: Message 7535034 . See also: Message 7582016 .

--RCM



To: tuck who wrote (90)2/26/1999 4:41:00 PM
From: BRAVEHEART  Read Replies (1) | Respond to of 423
 
Hi Tuck,

I have been intrigued by IMGN for 18 months or so. I have bought it several times at it's technical lows of $1 and proceeded to sell at highs of 2.5+. Right now the stock is experiencing Media Hype. Not a time when I like to buy. Unless I'm in before the hype. Todays WSJ stuff will result in my taking a back seat for a spell.

I look for technically undervalued ( IMGN is not in my mind per sae ) & Fundamentally Undervalued stocks ( Again IMGN on a risk basis is fairly valued at this time IMHO ). I will need to see longer support over this range to think otherwise.

Sure one can play it's ranges. Now it appears to be in a range between $2.25 and $3.50. Certainly the potential is there. R. Harmon has a much greater understanding of matters from a scientific perspective. I don't think he is convinced just yet.

Again I am intrigued by apoptosis. I hope it works out for IMGN and LXR. However this science is rather novel and unproven. Hence my risk aversion keeps me from making either a long Hold. While both have considerable potential if successful. In my mind LXR while more risky ( they need animal results yet & corporate confirmation ) is a much better play. Again the risks at LXR are rather High in May/June.

BEST WISHES
Jeffrey